Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/4/2017
SIETES contiene 91761 citas

 
 
 1 a 20 de 661 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas
Rochon PA, Vozoris N, Gill SS. The harms of benzodiazepines for patients with dementia . Can Med Assoc J 2017;189:E517-518. [Ref.ID 101525]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Taipale H, Tolppanen A-M, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S. Risk of pneumonia associated with incident benzodiazepine use among community- dwelling adults with Alzheimer disease. Can Med Assoc J 2017;189:E519-529. [Ref.ID 101524]
3. Cita con resumen
Khan AR, Bavishi C, Riaz H, Farid TA, Khan S, Atlas M, Hirsch G, Ikram S, Bolli R. Increased risk of adverse neurocognitive outcomes with proprotein convertase subtilisin-kexin type 9 inhibitors. Circulation: Cardiovascular Quality and Outcomes 2017;10:e003153. [Ref.ID 101377]
4.
Scheltens P, Blennow K, Breteler MMB, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM. Alzheimer's disease. Lancet 2016;388:505-17. [Ref.ID 100647]
5. Cita con resumen
Anónimo. Cannabis and cannabinoids. Med Lett Drugs Ther 2016;58:97-8. [Ref.ID 100510]
6. Cita con resumen
Norman JE, Marlow N, Messow C-M, Shennan A, Bennett PR, Thornton S, Robson SC, McConnachie A, Petrou S, Sebire NJ, Lavender T, Whyte S, Norrie J, for the OPPTIMUM study group. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet 2016;387:2106-16. [Ref.ID 100341]
7.Tiene citas relacionadas Cita con resumen
Kuller LH. Do proton pump inhibitors increase the risk of dementia?. JAMA Neurology 2016;73:379-81. [Ref.ID 100322]
8. Cita con resumen
Risacher SL, McDonald BC, Tallman EF, West JD, Farlow MR, Unverzagt FW, Gao S, Boustani M, Crane PK, Petersen RC, Jack Jr CR, Jagust WJ, Aisen PS, Weiner MW, Saykin AJ, for the Alzheimer's Disease Neuroimaging Initiative. Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults. JAMA Neurology 2016;73:721-32. [Ref.ID 100315]
9.Tiene citas relacionadas Cita con resumen
Gomm W, von Holt K, Thomé F, Broich K, Maier W, Fink A, Doblhammer G, Haenisch B. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurology 2016;73:410-6. [Ref.ID 100299]
10. Cita con resumen
Gray SL, Dublin S, Yu O, Walker R, Anderson M, Hubbard RA, Crane PK, Larson EB. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ 2016;352:i90. [Ref.ID 100037]
11.Tiene citas relacionadas Cita con resumen
Hall W, Lynskey M. Long-term marijuana use and cognitive impairment in middle age. JAMA Intern Med 2016;176:362-3. [Ref.ID 100010]
12.Tiene citas relacionadas Cita con resumen
Auer R, Vittinghoff E, Yaffe K, Kertesz SG, Levine DA, Albanese E, Whitmer RA, Jacobs Jr DR, Sidney S, Glymour MM, Pletcher MJ. Association between lifetime marijuana use and cognitive function in middle age: The Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA Intern Med 2016;176:352-61. [Ref.ID 100009]
13.Enlace a cita original Cita con resumen
Anónimo. Riesgos de los fármacos anticolinérgicos en personas de edad avanzada. Butlletí Groc 2015;28:1-4. [Ref.ID 99838]
14.Tiene citas relacionadas Cita con resumen
O'Brien JT, Thomas A. Vascular dementia. Lancet 2015;386:1698-706. [Ref.ID 99820]
15.Tiene citas relacionadas Cita con resumen
Walker Z, Possin KL, Boeve BF, Aarsland D. Lewy body dementias. Lancet 2015;386:1683-97. [Ref.ID 99819]
16.Tiene citas relacionadas Cita con resumen
Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet 2015;386:1672-82. [Ref.ID 99818]
17.Tiene citas relacionadas Cita con resumen
Odden MC. A discontinuation trial of antihypertensive treatment. The other side of the story. JAMA Intern Med 2015;175:1630-2. [Ref.ID 99649]
18.Tiene citas relacionadas
Anónimo. Dementia - not all about Alzeimer's. Lancet 2015;386:1600. [Ref.ID 99621]
19.Tiene citas relacionadas Cita con resumen
Moonen JEF, Foster-Dingley JC, de Ruijter W, van der Grond J, Bertens AS, van Buchem MA, Gussekloo J, Middelkoop HA, Wermer MJH, Westendorp RGJ, de Craen AJM, van der Mast RC. Effect of discontinuation of antihypertensive treatment in elderly people on cognitive funcioning - the DANTE study leiden: a randomized clinical trial. JAMA Intern Med 2015;175:1622-30. [Ref.ID 99606]
20.Tiene citas relacionadas Cita con resumen
Cummings JL, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW, De La Gandara JE, Agronin M, Davis CS, Nguyen U, Shin P, Tariot PNS, Siffert J. Effect of dextromethorphan-quinidine on agitation in patients with Alzheimer disease dementia: a randomized clinical trial. JAMA 2015;314:1242-54. [Ref.ID 99598]
Seleccionar todas
 
 1 a 20 de 661 siguiente >>